Viro-Immunological Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide among Women Living with HIV: A 96-Week Post-Switch Analysis from the Real-Life SHiNe-SHiC Cohort.
Colpani A, De Vito A, Marino A, Ceccarelli M, Celesia BM, Conti GN, Spampinato S, Moi G, Venanzi Rullo E, Pellicanò GF, Sofia SA, Pantò G, Iacobello C, Frasca CM, Montineri A, Albanese A, Angioni G, Cacopardo B, Madeddu G, Nunnari G, On Behalf Of Sardinian Hiv Network And Sicilian Hiv Cohort SHiNe-SHiC Research Group.
Colpani A, et al. Among authors: venanzi rullo e.
Biomedicines. 2024 Oct 11;12(10):2311. doi: 10.3390/biomedicines12102311.
Biomedicines. 2024.
PMID: 39457623
Free PMC article.